9 Feb 10

Written by Healthblognews.com. No comments

ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal Cancer

ArQule, Inc…

Filed under: GastroIntestinal - Trackback Uri

Dana-Farber And Sanford-Burnham Institute License Flu-Targeting Antibodies

Screening For Spinal Muscular Atrophy Not Cost Effective

Leave a Comment

wordpress visitor